Cargando…

Pregnant Patient on Hemodialysis Who Showed Remarkable Improvement of Severe Hyperparathyroidism by Strict Serum Phosphorus Control

We encountered a pregnant hemodialysis patient with severe hyperparathyroidism (HPT). Although her disease was considered to be refractory to medical treatment, the serum intact parathyroid hormone (PTH) level remarkably improved without manifestation of hypercalcemia through only strict serum phosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Jun, Fujii, Hideki, Kono, Keiji, Goto, Shunsuke, Nishi, Shinichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086312/ https://www.ncbi.nlm.nih.gov/pubmed/31735793 http://dx.doi.org/10.2169/internalmedicine.3774-19

Ejemplares similares

Clinical Implication of Consistently Strict Phosphate Control for Coronary and Valvular Calcification in Incident Patients Undergoing Hemodialysis
por: Shimizu, Mao, et al.
Publicado: (2023)

Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis
por: Watanabe, Kentaro, et al.
Publicado: (2020)

Clinical value of serum cholinesterase levels in Nephrotic syndrome: an observational study
por: Goto, Kimihiko, et al.
Publicado: (2022)

Two Cases of Hypophosphatemia with Increased Renal Phosphate Excretion in Legionella Pneumonia
por: Watanabe, Shuhei, et al.
Publicado: (2016)

Serum FGF23 levels may not be associated with serum phosphate and 1,25-dihydroxyvitamin D levels in patients with Fanconi syndrome–induced hypophosphatemia
por: Goto, Shunsuke, et al.
Publicado: (2016)

Influence of oxidative stress on vascular calcification in the setting of coexisting chronic kidney disease and diabetes mellitus
por: Watanabe, Shuhei, et al.
Publicado: (2020)

Changes of FGF23 and the Renin-Angiotensin-System in Male Mouse Models of Chronic Kidney Disease and Cardiac Hypertrophy
por: Okamoto, Kohei, et al.
Publicado: (2021)

Renin-Angiotensin System Inhibitors Reduce Serum Asymmetric Dimethylarginine Levels and Oxidative Stress in Normotensive Patients with Chronic Kidney Disease
por: Fujii, Hideki, et al.
Publicado: (2014)

Statin Use Influence on the Occurrence of Acute Kidney Injury in Patients with Peripheral Arterial Disease
por: Kanai, Daisuke, et al.
Publicado: (2022)

Characteristics of coronary artery disease in chronic kidney disease
por: Fujii, Hideki, et al.
Publicado: (2019)

Newly Developed Rat Model of Chronic Kidney Disease–Mineral Bone Disorder
por: Watanabe, Kentaro, et al.
Publicado: (2018)

Comparison of two protocols for steroid pulse therapy in patients with IgA nephropathy: a retrospective observational study
por: Yamatani, Satoshi, et al.
Publicado: (2022)

Renal protective effects of astragalus root in rat models of chronic kidney disease
por: Goto, Shunsuke, et al.
Publicado: (2023)

A Case of Fibrillary Glomerulonephritis with Fibril Deposition in the Arteriolar Wall and a Family History of Renal Disease
por: Watanabe, Kentaro, et al.
Publicado: (2017)

Changes in blood pressure during treatment with the tyrosine kinase inhibitor lenvatinib
por: Saito, Kei, et al.
Publicado: (2020)

Effect of enzyme replacement therapy on serum asymmetric dimethylarginine levels, coronary flow reserve and left ventricular hypertrophy in patients with Fabry disease
por: Fujii, Hideki, et al.
Publicado: (2012)

Remarkable Cure by Phosphorus
por: Buchmann,
Publicado: (1884)

Managing hyperparathyroidism in hemodialysis: role of etelcalcetide
por: Eidman, Keith E, et al.
Publicado: (2018)

Hemodialysis patients’ preferences for the management of secondary hyperparathyroidism
por: Hauber, Brett, et al.
Publicado: (2017)

The Effects of Plasma Exchange on Severe Vasculitis with Diffuse Alveolar Hemorrhage
por: Goto, Kimihiko, et al.
Publicado: (2017)

Serum Calcium/Phosphorus Ratio in Biochemical Screening of Primary Hyperparathyroidism
por: Bestepe, Nagihan, et al.
Publicado: (2022)

A case of a hemodialysis patient with secondary hyperparathyroidism who was resistant to etelcalcetide treatment but not to cinacalcet hydrochloride
por: Nakamura, Hironori, et al.
Publicado: (2021)

Comparison of Chronic Hemodialysis Patients under Strict Volume Control with respect to Cardiovascular Disease
por: Ersoy Dursun, Fadime, et al.
Publicado: (2019)

Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients
por: Shigematsu, Takashi, et al.
Publicado: (2018)

Strict convexity and complex strict convexity: theory and applications
por: Istratescu
Publicado: (1983)

A Single- and Multiple-Dose, Multicenter Study of Etelcalcetide in Japanese Hemodialysis Patients With Secondary Hyperparathyroidism
por: Yokoyama, Keitaro, et al.
Publicado: (2017)

Strict Isolation
por: Andersen, Bjørg Marit
Publicado: (2018)

Hypertension and hyperparathyroidism are associated with left ventricular hypertrophy in patients on hemodialysis
por: Al-Hilali, N., et al.
Publicado: (2009)

Parathyroidectomy Is Associated with Reduced Mortality in Hemodialysis Patients with Secondary Hyperparathyroidism
por: Ma, Tsung-Liang, et al.
Publicado: (2015)

PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2016)

Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
por: Alvarado, Luis, et al.
Publicado: (2022)

Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits
por: Chen, Xiu, et al.
Publicado: (2021)

Impact of parathyroidectomy among nondiabetic hemodialysis patients with severe hyperparathyroidism
por: Huang, Qing-xiu, et al.
Publicado: (2022)

Severe hyperparathyroidism is associated with nutritional impairment in maintenance hemodialysis patients
por: Disthabanchong, Sinee, et al.
Publicado: (2022)

Influence of Strict Lockdown on Vitamin D Deficiency in Pregnant Women: A Word of Caution
por: Agüero-Domenech, Nuria, et al.
Publicado: (2023)

PARATHORMONE DOSAGE AND SERUM CALCIUM AND PHOSPHORUS IN EXPERIMENTAL CHRONIC HYPERPARATHYROIDISM LEADING TO OSTITIS FIBROSA
por: Bodansky, Aaron, et al.
Publicado: (1931)

Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism?
por: Frazão, João M, et al.
Publicado: (2012)

Efficacy of microwave ablation for severe secondary hyperparathyroidism in subjects undergoing hemodialysis
por: Diao, Zongli, et al.
Publicado: (2016)

Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients
por: Cunningham, John, et al.
Publicado: (2019)

Fibrous dysplasia in maxilla in a patient on hemodialysis with severe secondary hyperparathyroidism
por: Yang, Hui-Hsin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vnnulhaa1tu5sv48774eerl9us